90 results about "Curative treatment" patented technology

The invention relates to pharmaceutical compositions for topical administration comprising a topically acceptable antiviral substance and an antiinflammatory glucocorticoid in a pharmaceutically acceptable carrier. The pharmaceutical composition can be used in the prophylactic and curative treatment of herpesvirus infections in mammals including man. The invention also relates to the use of a combination of a topically acceptable antiviral substance and an antiinflammatory glucocorticoid for the manufacture of a medicament for said prophylactic and curative treatment.

Patient support pads that form a part of conventional surgical tables are removed and replaced with pads that provide three dimensional volumetric pressure redistribution. The pads are releasably secured in overlying relation to conventional frame cushions that overlie the frame of a surgical table. Three pads are provided, one each for the head, torso, and foot section of the table so that the articulation of the table is not compromised by the pads. The pads not only prevent or inhibit the formation of decubitus ulcers during surgery but also provide therapeutic, curative treatment of the patient's dermis and epidermis by redistributing pressure without distorting or compressing soft tissue. A dual hose bifurcated manifold system connects each inflated pad to its contiguous inflated pad so that pressure applied in any one section of the surface is transmitted and redistributed over all of the inflated pads.

Described herein are a device and a method for the treatment of varicose veins via laser radiation, and in particular using a holmium laser. The radiation of a laser source (5) is injected in a fiber (3) that can be inserted in the vessel to be treated. The laser source emits a radiation such as to cause a hyalinizing sclerosis with structural modifications both to the fibers of the collagen (shrinkage) and to the extracellular matrix of the median coat of the vein by the photothermal effect, substantially without thermal stress of the morphological component of the tunica media and of the tunica intima.

This invention relates to method of diagnosing the presence and / or severity of a liver pathology and / or of monitoring the effectiveness of a curative treatment against a liver pathology in an individual, leading to a score, comprising the combination, of at least one blood test and of at least one data issued from a physical method of diagnosing liver fibrosis, said data being selected from the group consisting of medical imaging data and clinical measurements, said combination being performed through a mathematical function.This invention also relates to a method wherein the combination through a mathematical function, of at least one blood test and of at least one data issued from a physical method of diagnosing liver fibrosis, is performed at least twice and the at least two resulting scores are combined in an algorithm based on the diagnostic reliable intervals.

The present invention relates to use of vegetable oils such as soybean oil as an adjuvant for substances having a fungicide, bactericide and insecticide activity in preventive or curative treatments of plant diseases caused by fungi, bacteria and insects on agricultural cultivations. In addition, the present invention relates to use of vegetable oils such as soybean oil as an adjuvant for substances having a herbicide activity in treatments for weed control on agricultural cultivations. Finally, the present invention relates to a fungicide, bactericide, insecticide or herbicide composition characterized in that it comprises: a stable water emulsion of vegetable oils such as soybean oil; and at least one substance having a fungicide, bactericide, insecticide or herbicide activity.

The present invention relates to a method for detecting one or more indicator(s) of the probable onset of a chronic obstructive pulmonary disease (COPD) exacerbation; primers for use in the method; a computer model using detection of one or more indicator(s) to the probable onset of a COPD exacerbation for patient management and the prophylactic or curative treatment of COPD exacerbation and to a prognostic and / or diagnostic test for use in the detection of one or more indicator(s) to the probable onset of a COPD exacerbation.

The invention relates to pharmaceutical compositions for topical administration comprising a topically acceptable antiviral substance and an antiinflammatory glucocorticoid in a pharmaceutically acceptable carrier. The pharmaceutical composition can be used in the prophylactic and curative treatment of herpesvirus infections in mammals including man. The invention also relates to the use of a combination of a topically acceptable antiviral substance and an antiinflammatory glucocorticoid for the manufacture of a medicament for said prophylactic and curative treatment.

PCT No. PCT / SE96 / 00123 Sec. 371 Date Mar. 8, 1996 Sec. 102(e) Date Mar. 8, 1996 PCT Filed Feb. 2, 1996 PCT Pub. No. WO96 / 24359 PCT Pub. Date Aug. 15, 1996The invention relates to a pharmaceutical composition for topical administration comprising a combination of foscarnet and an antiinflammatory glucocorticoid, in admixture with a carrier based on galactolipids and a polar solvent. The pharmaceutical composition can be used in a prophylactic and / or curative treatment of herpesvirus infections in mammals including man. The invention also relates to the use of said pharmaceutical composition in the manufacture of a medicament for said prophylactic or curative treatment.

The present invention relates to a therapeutic vaccine comprising one or more survivin polypeptide fragments. The vaccine can be used for prophylactic, ameliorating and / or curative treatment of e.g. cancer diseases. The invention further relates to methods of combination treatment.

The invention relates to a real time curative treatment data hunting system used in a communication system, utilizing a storage device mounted in the sever to store map information, the map information includes complex number interlink fixed points, each interlink fixed point corresponds a position information and is connected with correspond curative treatment data via net, a position of the mobile communication device relative to the map information is measured by using a locating mould, a input information is input and transferred to the sever by using a hunting mould, in predetermined range of the measured position of the mobile communication device relative to the map information, to select curative treatment data which accords with the input information by inter-comparing the curative treatment data connected by interlink fixed point in the predetermined range, finally, the curative treatment data is indicated by a display of the mobile communication device.

A composition made from at least one probiotic for the use of same in the curative treatment of body weight gain in an overweight human and / or in the preventive treatment of body weight gain in a human who is overweight or has been overweight, said probiotic being Bifidobacterium animalis ssp. Iactis n DEG LMG P-28149.

The present application relates to a sub-region of a Plasmodium protein, with improved vaccine potential, and to medical uses thereof, notably for treatment or diagnosis of malaria. The present invention notably provides unstructured or unfolded polypeptides deriving from the PFF0165c protein of P. falciparum 3D7. The polypeptides of the invention have a high antigenicity, a high immunogenicity, have a high parasite-killing activity in the ADCI assay, and are strongly associated with clinical protection against malaria, and. The present invention thereby provides a vaccine for the palliative and / or curative treatment of malaria, which is specifically intended for infants, toddlers, children under the age of 5, pregnant women.

The invention relates to the combined use of a PDE4 inhibitor with a HMG-CoA reductase inhibitor for the prevention and curative treatment of an inflammatory pulmonary disease.

The invention provides a Chinese traditional medicine external use hypurgia preparation for resisting bacteria and relieving itching and pertains to the technical field of Chinese traditional preparation, which is characterized in that the preparation is made by the following material drugs, and each dosage includes: 72-78g of moxa leaf, 77-83g of perilla leaf, 42-48g of senecio scandens, 17-23g of dry ginger, 32-38g of andrographis paniculata and 67-73g of motherwort. Moxa leaf, perilla leaf, senecio scandens, dry ginger, andrographis paniculata and motherwort are taken as the material drugs for preparing the Chinese traditional medicine external use hypurgia preparation for resisting bacteria and relieving itching, which is decocted by water for soaking and washing and have better effect if drugs are used together. By using the Chinese traditional medicine, the period of curative treatment is short, skin exuviation and allergy can not be caused, dermatophytosis, miliaria and prurtus can be cured radically and can not recur, and the curative effect is outstanding. And the Chinese traditional medicine can not stimulate human body and has not side effect, and can be used as a hypurgia preparation of lavipeditum and bath for soaking and washing.

The invention relates to the combined use of a PDE4 inhibitor with a HMG-CoA reductase inhibitor for the preventive and curative treatment of an inflammatory pulmonary disease.

The present invention relates to the preventive or curative treatment of metabolic syndrome and the associated disorders with AhR agonist or microorganism producing AhR agonist.

The present invention pertains to the use of subunits and oligomers of collectins and / or ficolins, such as mannan-binding lectin (MBL) in prophylactic and / or curative treatment of Severe Acute Respiratory Syndrome (SARS) in an individual.

Provided are uses of erythropoietin, or a derivative or functional analogue thereof, for the production of a medicament for the preventive or curative treatment of patients suffering from, or at risk of suffering from, cardiac failure.

The present invention pertains to the use of subunits and oligomers of mannan- binding lectin (MBL) in prophylactic and / or curative treatment of an immunocompromised individual such as subjects suffering from solid tumors or haematological cancers. Solid tumors include such as female cancers, male cancers, cancers of the respiratory system, cancers of the gastro intestinal system, the renal system and further subjects suffering from thyroid cancer and melanomas. Haematological cancers include leukaemia, lymphoma and myeloma. The immunocompromised condition of the individual may be due to a cancer disease as mentioned herein or the treatment of said cancer disease.

An in vitro method for screening candidate compounds for the preventive or curative treatment of acne, includes the determination of the capacity of a compound to modulate the expression or the activity of UDP-glucose ceramide glucosyltransferase (UGCG), and the use of modulators of the expression or activity of this enzyme for the treatment of acne or skin disorders associated with a hyperkeratinization; methods for the in vitro diagnosis or prognosis of these pathologies are also described.

An in vitro method for screening candidate compounds for the preventive or curative treatment of acne, includes the determination of the capacity of a compound to modulate the expression or the activity of sterol-C4-methyl oxidase (SC4MOL), and the use of modulators of the expression or activity of this enzyme for the treatment of acne or skin disorders associated with a hyperseborrhea; methods for the in vitro diagnosis or prognosis of these pathologies are also described.

The present invention describes a series of derivatives of 2-(3-methylenedioxy)-benzoyl indol, their mixtures, their pharmaceutically acceptable salts, their enantiomers, pharmaceutical compositions comprising them, processes for preparing them, use in the prophylactic and / or curative treatment of sexual dysfunction. More specifically, the invention describes derivatives (R)-3-((2-(benzo[d][1,3]dioxol-5-carbonyl)-1H-indol-3-yl)methyl)-1-methylpiperazine-2,5-dione, and S)-3-((2-(benzo[d][1,3]dioxol-5-carbonyl)-1H-indol-3-yl)methyl)-1-methylpiperazine-2,5-dione.

The present invention pertains to the use of subunits and oligomers of mannan-binding lectin (MBL) in prophylactic and / or curative treatment of an immunocompromised individual such as subjects suffering from solid tumors or haematological cancers. Solid tumors include such as female cancers, male cancers, cancers of the respiratory system, cancers of the gastro intestinal system, the renal system and further subjects suffering from thyroid cancer and melanomas. Haematological cancers include leukaemia, lymphoma and myeloma. The immunocompromised condition of the individual may be due to a cancer disease as mentioned herein or the treatment of said cancer disease.

This invention discloses composition and manufacturing processes of a toxicity free botanical drug formulation for curative treatment of chronic diseases. It is manufactured from plants Crinum asiaticum and Crocus sativus. This drug was administered to human volunteers by oral and intranasal routes in effective amount for an effective time period. Effective amount and effective time of administration varies from one human volunteer to another depending upon age, body weight, length of disease, severity of disease, type of the disease. In vitro experiments show that this botanical drug causes proliferation and differentiation of stem cells.

A method for discrete pest management, preferably for public accommodations. The service provider dresses and behaves as a usual repairperson for the establishment. The attire of the service provider does not bear any logos or emblems that would indicate a need to patrons for pest management. Inspections are conducted, and a quality assurance seal is provided if no infestation is detected. If an infestation is detected, an extermination provider is arranged to apply curative treatment. The extermination provider is trained in the discretionary tactics of the service provider, and conducts itself on the customer's property the same as the service provider. Once the infestation is eradicated, a quality assurance seal is provided. The service provider may offer a comprehensive pest package, or may only offer service for a particular pest. Periodic inspections are conducted by the service provider for uninterrupted quality assurance during the term of the contract.

The invention relates to a novel medical diagnostic method and treatment in conjunction with depression-inducing genes which are stimulated in particular by interferon. The invention relates in particular to the use of at least one nucleic acid molecule which induces depression and / or is associated with depression, in particular a gene and / or the DNA sequence thereof and / or the RNA sequence associated therewith, and / or a (poly)peptide encoded by the nucleic acid, for finding and / or providing a diagnostic method for detecting depression, or a medicament for the preventive and / or curative treatment of depression, and / or for determining the risk of developing depression, and / or for predicting the individual effects and / or side-effects of medicaments, in particular for treatment with interferon (for example, for the treatment of hepatitis).

The invention discloses a multipurpose physical therapy health care hat, relating to physical therapy health care products of human brain health. The health care hat is provided with an inner cavity for accommodating a head and also sequentially provided with a curative treatment layer containing Chinese herbal medicine, a phototherapy layer made of infrared ray non-woven fabrics, a moxibustion therapy layer made of anion glue-spreading cotton, a magnetotherapy layer made of far infrared glue-spreading cotton and an anti-radiation layer made of radiation proof non-woven fabrics from the inner cavity to the outside. The health care hat can improve brain environment, effectively prevent and treat symptoms, such as insomnia, alopecia, neurasthenia, memory impairment, headache and dizziness, and the like and effectively prevent repeated outbreak of hypertension, stroke hemiplegia, senile dementia, parkinsonismus, and the like.

The use of a compound of formula (I) an isomer thereof, a prodrug of said compound or isomer, or a pharmaceutically acceptable salt of said compound, isomer or prodrug, in the manufacture of a medicament for the palliative, prophylactic or curative treatment of negative energy balance in ruminants. The use of a compound of formula 1, in the manufacture of a medicament for the palliative, prophylactic or curative treatment of ruminant disease associated with negative energy balance in ruminants, wherein, preferably, the ruminant disease associated with negative energy balance in ruminants is selected from fatty liver syndrome, dystocia, immune dysfunction, impaired immune function, toxification, primary ketosis, secondary ketosis, downer cow syndrome, indigestion, inappetence, retained placenta, displaced abomasum, mastitis, (endo-)-metritis, infertility, low fertility, and lameness.